Skip to main content
Industry News
GSK, Vir's COVID-19 antibody drug gets EUA from FDA

GlaxoSmithKline and Vir Biotechnology's monoclonal antibody drug Sotrovimab has received emergency use authorization from the FDA for the treatment of patients ages 12 and older with mild to moderate COVID-19. The drug should not be used for cases of COVID-19 that require hospitalization or oxygen therapy, the FDA said.

Full Story: